期刊文献+

耐碳青霉烯类肠杆菌科细菌的耐药机制探讨 被引量:6

Mechanism of carbapenems-resistant Enterobacteriaceae
下载PDF
导出
摘要 目的探讨耐碳青霉烯类肠杆菌科细菌的耐药机制。方法收集上海交通大学附属第六人民医院2011年1月—2013年12月临床分离到的80株碳青霉烯类抗菌药物耐药的肠杆菌科细菌,采用Vitek Compao60鉴定系统进行细菌鉴定和药物敏感性检测,用纸片扩散法检测细菌对亚胺培南和美罗培南的敏感性,用改良Hodge试验、抑制剂的双纸片增效试验检测碳青霉烯酶表型,用聚合酶链反应(PCR)检测blaKPC、blaIMP、blaOXA23、blaOXA51、blaOXA48、blaVIM、blaNMD。结果 80株菌株对常见多种抗菌药物耐药;改良Hodge试验和硼酸抑制试验与KPC酶检测的一致率分别为47.5%和97.5%;blaKPC、blaIMP、blaOXA23、blaOXA51、blaOXA48、blaVIM和blaNMD的检出率分别为88.75%、5.00%、3.75%、3.75%、0.00%、0.00%和0.00%,所有基因均阴性的检出率为5.00%。结论上海交通大学附属第六人民医院肠杆菌科细菌耐碳青霉烯类抗菌药物的主要机制是携带KPC-2型碳青霉烯酶,硼酸抑制试验能快速、准确地检测出KPC酶。 Objective To study the mechanism of carbapenems-resistant Enterobacteriaceae. Methods A total of 80 isolates of Enterobacteriaceae being resistant to carbapenems were isolated from patients in Shanghai Sixth People's Hospital from January 2011 to December 2013. The isolates were identified by Vitek Compao60 automatic system,and antimicrobial susceptibility was determined as well. The susceptibilities to imipenem and meropenem were determined Kirby-Bauer disc diffusion method. The modified Hodge test and inhibitor-potentiated double-disc diffusion test were performed for determining carbapenemase phenotype. Polymerase chain reaction(PCR) was performed for determining blaKPC,blaIMP,blaOXA23,blaOXA51,blaOXA48,blaVIM and blaNMD. Results The isolates were resistant to many antibiotics. The consistencies of modified Hodge test and aminophenylboronic acid inhibition test to KPC were 47.5% and 97.5%. The determination rates of blaKPC,blaIMP,blaOXA23,blaOXA51,blaOXA48,blaVIM and blaNMD were 88.75%,5.00%,3.75%,3.75%,0.00%,0.00% and 0.00%. The determination rate of isolates being negative for all the tested genes was 5.00%.Conclusions KPC-2 carbapenemase is the main mechanism of carbapenems-resistant Enterobacteriaceae in Shanghai Sixth People's Hospital. The inhibitor-potentiated double-disc diffusion test can determine KPC easily and correctly.
出处 《检验医学》 CAS 2017年第12期1080-1084,共5页 Laboratory Medicine
基金 上海市卫生和计划生育委员会科研课题(201540096)
关键词 肠杆菌科细菌 碳青霉烯酶 改良HODGE试验 双纸片增效试验 KPC Enterobacteriaceae Carbapenemase Modified Hodge test Inhibitor-potentiated double-disc diffusion test KPC
  • 相关文献

参考文献1

  • 1胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:622

二级参考文献17

  • 1Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 3Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 4Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 5Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 6van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 7Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.
  • 8Tascini C. Tagliaferri E. Giani T. et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPCproducing Klebsiella pneumoniae [J]. Antimicrob Agents Chernother , 2013. 57 (8): 3990-3993.
  • 9Pulcini C. Bush K. Craig WA. et al. Forgotten Antibiotics: an Inventory in Europe. the United States. Canada. and Australia[J]. Clin Infect Dis. 2012. 54(2): 268-274.
  • 10Falagas ME. Giannopoulou KP. Kokolakis GN. et al. Fosfomycin , use beyond urinary tract and gastrointestinal infections [J]. Clin Infect Dis. 2008. 46(7): 1069-1077.

共引文献621

同被引文献57

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部